Skip to content

Clinical trials

Active, not recruiting Phase 2 Inflammatory Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Phase: Phase 2 Status: Active, not recruiting Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20151
20162
20173
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
City of Hope Medical Center2
Academic and Community Cancer Research United1
Dana-Farber Cancer Institute1
Institut Paoli-Calmettes1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms10
Breast Neoplasms4
Triple Negative Breast Neoplasms4
Edema2
Erythema2
Breast Neoplasms, Male1
Carcinoma, Ductal, Breast1
Carcinoma, Lobular1
Unilateral Breast Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.